Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Dexmedetomidine for Quality of Emergence from General Anesthesia
NCT02141412Phase 4Completed
- Sponsor
- American University of Beirut Medical Center
- Start
- Sep 2009
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative shivering and Anesthesia emergence (4 arms), sponsored by American University of Beirut Medical Center. Primary endpoints: Postanaesthetic shivering incidence and score and Quality of emergence from anesthesia. Started Sep 2009; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative shiveringAnesthesia emergence
Beyond the preview
Go deeper on NCT02141412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141412.